Name | ethyl 3-oxo-3-pyridin-4-ylpropanoate |
---|---|
Synonyms |
Ethyl 3-oxo-3-(4-pyridinyl)propanoate
Ethyl isonicotinylacetate 4-Pyridinepropanoicacid ETHYL 3-OXO-3-(4-PYRIDYL)PROPIONATE ethyl-4-pyridoyl acetate 4-Pyridinepropanoic acid, β-oxo-, ethyl ester EINECS 247-635-1 Ethyl Isonicotinoylacetate MFCD00094021 Ethyl 3-oxo-3-(pyridin-4-yl)propanoate |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 292.0±15.0 °C at 760 mmHg |
Melting Point | 53-59 °C |
Molecular Formula | C10H11NO3 |
Molecular Weight | 193.199 |
Flash Point | 130.4±20.4 °C |
Exact Mass | 193.073898 |
PSA | 56.26000 |
LogP | 0.44 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.511 |
Synonym:None Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: None Listed. Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated. Potential Health Effects Eye: May cause eye irritation. The toxicological properties of this material have not been fully investigated. Skin: May cause skin irritation. The toxicological properties of this material have not been fully investigated. Ingestion: May cause irritation of the digestive tract. Ingestion of large amounts may cause gastrointestinal irritation. The toxicological properties of this substance have not been fully investigated. Inhalation: May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Chronic: No information found. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Ingestion: Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid if cough or other symptoms appear. Notes to Physician: Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 26377-17-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Solid Color: Not available. Odor: Not available. pH: Not available. Vapor Pressure: Negligible. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 56 - 59 deg C Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: Molecular Weight: 193.20 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: High temperatures, incompatible materials, dust generation, excess heat. Incompatibilities with Other Materials: Oxidizing agents. Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide. Hazardous Polymerization: Will not occur. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 26377-17-3 unlisted. LD50/LC50: Not available. Carcinogenicity: Ethylisonicotinoyl Acetate - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: Not available. Risk Phrases: Safety Phrases: S 24/25 Avoid contact with skin and eyes. S 28A After contact with skin, wash immediately with plenty of water. S 37 Wear suitable gloves. S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). WGK (Water Danger/Protection) CAS# 26377-17-3: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 26377-17-3 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 26377-17-3 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
~86% 26377-17-3 |
Literature: Venkat Ragavan; Vijayakumar; Rajesh; Palakshi Reddy; Karthikeyan; Suchetha Kumari Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 12 p. 4193 - 4197 |
~42% 26377-17-3 |
Literature: BAYER AKTIENGESELLSCHAFT Patent: WO2003/106450 A1, 2003 ; Location in patent: Page column 39,40 ; WO 03/106450 A1 |
~25% 26377-17-3 |
Literature: Alam, Muzaffar; Du Bois, Daisy Joe; Hawley, Ronald Charles; Kennedy-Smith, Joshua; Minatti, Ana Elena; Palmer, Wylie Solang; Silva, Tania; Wilhelm, Robert Stephen Patent: US2011/71150 A1, 2011 ; Location in patent: Page/Page column 27 ; |
~% 26377-17-3 |
Literature: GLAXO GROUP LIMITED; JOHNS, Brian Alvin; SHOTWELL, John Brad Patent: WO2012/67664 A1, 2012 ; Location in patent: Page/Page column 31 ; |
~74% 26377-17-3 |
Literature: SANOFI-SYNTHELABO; Mitsubishi-Tokyo Pharmaceuticals, Inc. Patent: EP1136483 A1, 2001 ; EP 1136483 A1 |
~91% 26377-17-3 |
Literature: Carabateas; Brundage; Gelotte; et al. Journal of Heterocyclic Chemistry, 1984 , vol. 21, # 6 p. 1849 - 1856 |
~41% 26377-17-3 |
Literature: BAYER HEALTHCARE AG Patent: WO2004/39796 A1, 2004 ; Location in patent: Page/Page column 73-74 ; WO 2004/039796 A1 |
~% 26377-17-3 |
Literature: Sugasawa; Tomisawa Pharmaceutical Bulletin, 1955 , vol. 3, p. 32 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |